NSCLC TARGETED THERAPY AND CIRCULATING BIOMARKERS

Plasma ctDNA analysis for detection of EGFR T790M mutation in patients (pts) with EGFR mutation-positive advanced non-small cell lung cancer (aNSCLC)

S. Jenkins